SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism

1. M. Onorato, A.
2. Fiore, E.
3. Bayo, J.
4. Casali, C.
5. Fernandez-Tomé, M.
6. Rodríguez, M.
7. Domínguez, L.
8. Argemi, J.
9. Hidalgo, F.
10. Favre, C.
11. García, M.
12. Atorrasagasti, C.
13. Mazzolini, G.D.